If there may be significant potential benefits, IV thrombolysis may be reasonable (class IIa, level of evidence B).
← all excerpts
Chinese Stroke Association guidelines for clinical management of cerebrovascular disorders: executive summary and 2019 update of clinical management of ischaemic cerebrovascular diseases.
1
—
—